MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia
Authors
Keywords
-
Journal
ONCOGENE
Volume 31, Issue 1, Pages 80-92
Publisher
Springer Nature
Online
2011-06-06
DOI
10.1038/onc.2011.208
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer
- (2010) Xiaobo Guo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer
- (2010) Vera N Senchenko et al. BMC CANCER
- Sp1/NFκB/HDAC/miR-29b Regulatory Network in KIT-Driven Myeloid Leukemia
- (2010) Shujun Liu et al. CANCER CELL
- Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: Clinical and prognostic significance
- (2010) Amlan Ghosh et al. CANCER SCIENCE
- microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia
- (2010) Yoon-Chi Han et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer
- (2010) Ankur K. Nagaraja et al. MOLECULAR ENDOCRINOLOGY
- Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia
- (2009) J. A. Pulikkan et al. BLOOD
- MicroRNA 29b functions in acute myeloid leukemia
- (2009) R. Garzon et al. BLOOD
- miR-34b Targets Cyclic AMP-Responsive Element Binding Protein in Acute Myeloid Leukemia
- (2009) M. Pigazzi et al. CANCER RESEARCH
- MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation
- (2009) K-H Lee et al. ONCOGENE
- A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes
- (2009) S Careccia et al. ONCOGENE
- High Mutability of the Tumor Suppressor Genes RASSF1 and RBSP3 (CTDSPL) in Cancer
- (2009) Vladimir I. Kashuba et al. PLoS One
- MicroRNA Patterns Associated with Clinical Prognostic Parameters and CNS Relapse Prediction in Pediatric Acute Leukemia
- (2009) Hua Zhang et al. PLoS One
- Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis
- (2009) Katia R.M. Leite et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia
- (2008) M. Jongen-Lavrencic et al. BLOOD
- Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling
- (2008) Jianrong Wang et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation
- (2008) Marina Bousquet et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Downregulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1, and HYAL2 in non-small cell lung cancer
- (2008) E. A. Anedchenko et al. MOLECULAR BIOLOGY
- Distinctive Patterns of MicroRNA Expression Associated with Karyotype in Acute Myeloid Leukaemia
- (2008) Amanda Dixon-McIver et al. PLoS One
- Distinct microRNA expression profiles in acute myeloid leukemia with common translocations
- (2008) Z. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started